Cargando…
Airflow obstruction: is it asthma or is it COPD?
Despite the availability of guideline recommendations, diagnostic confusion between COPD and asthma appears common, and often it is very difficult to decide whether the obstruction is caused by asthma or COPD in a patient with airway obstruction. However, there are well-defined features that help in...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137932/ https://www.ncbi.nlm.nih.gov/pubmed/27942210 http://dx.doi.org/10.2147/COPD.S54927 |
_version_ | 1782471985042817024 |
---|---|
author | Rogliani, Paola Ora, Josuel Puxeddu, Ermanno Cazzola, Mario |
author_facet | Rogliani, Paola Ora, Josuel Puxeddu, Ermanno Cazzola, Mario |
author_sort | Rogliani, Paola |
collection | PubMed |
description | Despite the availability of guideline recommendations, diagnostic confusion between COPD and asthma appears common, and often it is very difficult to decide whether the obstruction is caused by asthma or COPD in a patient with airway obstruction. However, there are well-defined features that help in differentiating asthma from COPD in the presence of fixed airflow obstruction. Nonetheless, the presentations of asthma and COPD can converge and mimic each other, making it difficult to give these patients a diagnosis of either condition. The association of asthma and COPD in the same patient has been designated mixed asthma–COPD phenotype or overlap syndrome. However, since the absence of a clear definition and the inclusion of patients with different characteristics under this umbrella term, it may not facilitate treatment decisions, especially in the absence of clinical trials addressing this heterogeneous population. We are realizing that neither asthma nor COPD are single diseases, but rather syndromes consisting of several endotypes and phenotypes, consequently comprising a spectrum of diseases that must be recognized and adequately treated with targeted therapy. Therefore, we must treat patients by personalizing therapy on the basis of those treatable traits present in each subject. |
format | Online Article Text |
id | pubmed-5137932 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-51379322016-12-09 Airflow obstruction: is it asthma or is it COPD? Rogliani, Paola Ora, Josuel Puxeddu, Ermanno Cazzola, Mario Int J Chron Obstruct Pulmon Dis Review Despite the availability of guideline recommendations, diagnostic confusion between COPD and asthma appears common, and often it is very difficult to decide whether the obstruction is caused by asthma or COPD in a patient with airway obstruction. However, there are well-defined features that help in differentiating asthma from COPD in the presence of fixed airflow obstruction. Nonetheless, the presentations of asthma and COPD can converge and mimic each other, making it difficult to give these patients a diagnosis of either condition. The association of asthma and COPD in the same patient has been designated mixed asthma–COPD phenotype or overlap syndrome. However, since the absence of a clear definition and the inclusion of patients with different characteristics under this umbrella term, it may not facilitate treatment decisions, especially in the absence of clinical trials addressing this heterogeneous population. We are realizing that neither asthma nor COPD are single diseases, but rather syndromes consisting of several endotypes and phenotypes, consequently comprising a spectrum of diseases that must be recognized and adequately treated with targeted therapy. Therefore, we must treat patients by personalizing therapy on the basis of those treatable traits present in each subject. Dove Medical Press 2016-11-30 /pmc/articles/PMC5137932/ /pubmed/27942210 http://dx.doi.org/10.2147/COPD.S54927 Text en © 2016 Rogliani et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Rogliani, Paola Ora, Josuel Puxeddu, Ermanno Cazzola, Mario Airflow obstruction: is it asthma or is it COPD? |
title | Airflow obstruction: is it asthma or is it COPD? |
title_full | Airflow obstruction: is it asthma or is it COPD? |
title_fullStr | Airflow obstruction: is it asthma or is it COPD? |
title_full_unstemmed | Airflow obstruction: is it asthma or is it COPD? |
title_short | Airflow obstruction: is it asthma or is it COPD? |
title_sort | airflow obstruction: is it asthma or is it copd? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137932/ https://www.ncbi.nlm.nih.gov/pubmed/27942210 http://dx.doi.org/10.2147/COPD.S54927 |
work_keys_str_mv | AT roglianipaola airflowobstructionisitasthmaorisitcopd AT orajosuel airflowobstructionisitasthmaorisitcopd AT puxedduermanno airflowobstructionisitasthmaorisitcopd AT cazzolamario airflowobstructionisitasthmaorisitcopd |